Brief: Valbiotis Presents First Market Data On Untreated LDL-Hypercholesterolemia For Totum-070

Valbiotis SA

27/10/2020 17:27

Oct 27 (Reuters) - VALBIOTIS SA  ALVAL.PA :
    * VALBIOTIS PRESENTS THE FIRST MARKET DATA ON UNTREATED
LDL-HYPERCHOLESTEROLEMIA FOR TOTUM-070, AND ANNOUNCES THE
INITIATION OF THE PHASE II CLINICAL STUDY HEART
    * TOTUM-070 HAS HIGH POTENTIAL IN MARKET FOR NON-DRUG
LDL-CHOLESTEROL PRODUCTS, WHICH IS ESTIMATED AT 1.2 BILLION
EUROS

Source text for Eikon:  ID:nBw9FcLBSa 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))